Ann: Managing Director Resignation-AHZ.AX, page-107

I wouldnt pay much attention to that superstition bs, a lot of good can come out of the US too. The company will be regarded, respected and valued much differently if we listed over there. IF the unblinded data is as good as the interim data then the company market cap will be many multiples from here here. We will more than likely see a lot of interest coming in from the US, we could well be seeing partnerships with upfronts and royalties - highly likey with a US pharma and this may not a bad thing at all. The fact that any staff members have a any company on their CV does not mean 'they're a hack' this is crazy talk. Each situation has to be looked at individually as evidence and facts and circumstances arise.